Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$1.32B |
| 2 |
AbbVie
ABBV
|
+$724M |
| 3 |
Salesforce
CRM
|
+$712M |
| 4 |
GE Aerospace
GE
|
+$660M |
| 5 |
Global Payments
GPN
|
+$623M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.73B |
| 2 |
Netflix
NFLX
|
+$1.14B |
| 3 |
PayPal
PYPL
|
+$1.1B |
| 4 |
Norfolk Southern
NSC
|
+$1.09B |
| 5 |
Cisco
CSCO
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 15.11% |
| 3 | Healthcare | 14.36% |
| 4 | Consumer Discretionary | 11.42% |
| 5 | Communication Services | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Ligand Pharmaceuticals
LGND
$6.36B
| $6.53M | ﹤0.01% |
105,206
-98,859
| -48% | -$6.21M |
|
1877
CytomX Therapeutics
CTMX
$754M
| $6.53M | ﹤0.01% |
884,726
-438,485
| -33% | -$4.33M |
|
1878
Alpha and Omega Semiconductor
AOSL
$1.08B
| $6.48M | ﹤0.01% |
527,896
-941,600
| -64% | -$10.4M |
|
|
APLT
1879
DELISTED
Applied Therapeutics
APLT
| $6.44M | ﹤0.01% |
586,130
| – | – |
|
1880
BioXcel Therapeutics
BTAI
$27.8M
| $6.41M | ﹤0.01% |
56,912
+12,738
| +29% | +$2.01M |
|
1881
Goodyear
GT
$1.85B
| $6.35M | ﹤0.01% |
440,985
+238,179
| +117% | +$3.17M |
|
1882
Viemed Healthcare
VMD
$371M
| $6.32M | ﹤0.01% |
+916,280
| New | +$6.11M |
|
1883
Varex Imaging
VREX
$523M
| $6.31M | ﹤0.01% |
220,989
-233,229
| -51% | -$6.75M |
|
1884
Kohl's
KSS
$2.19B
| $6.23M | ﹤0.01% |
125,541
-220,419
| -64% | -$10.8M |
|
1885
Graham Holdings Company
GHC
$5.02B
| $6.23M | ﹤0.01% |
9,391
+54
| +0.6% | +$38.3K |
|
1886
Teva Pharmaceuticals
TEVA
$41.2B
| $6.22M | ﹤0.01% |
903,411
-5,192,953
| -85% | -$39.8M |
|
1887
Markel Group
MKL
$23.2B
| $6.2M | ﹤0.01% |
5,248
+1,736
| +49% | +$1.97M |
|
1888
RLJ Lodging Trust $1.95 Series A Preferred Stock
RLJ.PRA
$322M
| $6.2M | ﹤0.01% |
230,335
| – | – |
|
|
STKL
1889
DELISTED
SunOpta
STKL
| $6.2M | ﹤0.01% |
3,430,840
-53,554
| -2% | -$139K |
|
1890
Community Trust Bancorp
CTBI
$1.41B
| $6.19M | ﹤0.01% |
145,376
-30,000
| -17% | -$1.23M |
|
1891
Vanguard Information Technology ETF
VGT
$149B
| $6.11M | ﹤0.01% |
226,648
+17,632
| +8% | +$475K |
|
1892
Everest Group
EG
$14.4B
| $6.09M | ﹤0.01% |
22,872
-871
| -4% | -$220K |
|
1893
Pinterest
PINS
$13.4B
| $6.08M | ﹤0.01% |
229,818
-95,333
| -29% | -$2.86M |
|
|
PSXP
1894
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $6.05M | ﹤0.01% |
106,800
| – | – |
|
1895
Aurinia Pharmaceuticals
AUPH
$2.11B
| $6.01M | ﹤0.01% |
1,125,744
-2,174,346
| -66% | -$13.2M |
|
|
FINV
1896
FinVolution Group
FINV
$1.15B
| $5.96M | ﹤0.01% |
2,055,277
-1,314,872
| -39% | -$5.03M |
|
1897
EnerSys
ENS
$6.99B
| $5.96M | ﹤0.01% |
90,351
+89,722
| +14,264% | +$5.63M |
|
1898
Replimune Group
REPL
$1.01B
| $5.95M | ﹤0.01% |
428,012
| – | – |
|
1899
StoneX
SNEX
$7.94B
| $5.91M | ﹤0.01% |
729,066
-1,206,687
| -62% | -$9.46M |
|
|
ZAYO
1900
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $5.9M | ﹤0.01% |
174,100
-334,926
| -66% | -$11.3M |
|
Similar funds
Fidelity Investments's Q3 2019 Portfolio in Review
As of Q3 2019, Fidelity Investments held 4,503 positions worth $834B, down 2.6% from $856B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Fidelity Investments's Q3 2019 filing shows 385 new, 1,486 increased, 1,638 reduced and 347 closed positions. Its largest new stake was Cloudflare: 19,681,830 shares worth $339M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Fidelity Investments's largest Q3 2019 buy was Cloudflare: 19,681,830 shares worth $339M.
- Fidelity Investments added most to Fidelity National Information Services in Q3 2019, an estimated $1.32B increase.
- Fidelity Investments's biggest Q3 2019 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $1.73B.
- Fidelity Investments fully exited Array Biopharma Inc in Q3 2019, selling an estimated $890M.
- Fidelity Investments's ten largest holdings make up 22% of its $834B portfolio in Q3 2019.
- Fidelity Investments opened 385 new positions and closed 347 in Q3 2019.
- Fidelity Investments's portfolio value fell 2.6% quarter-over-quarter to $834B.
Based on Fidelity Investments's 13F filing for Q3 2019, filed 13 Nov 2019.